GC
INFI

Globeflex Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Globeflex Capital’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-204,399
Closed -$272K – 559
2016
Q2 		$272K Buy
204,399
+146,000
+250% +$683K 0.07% 306
2016
Q1 		$308K Sell
58,399
-75,700
-56% -$463K 0.08% 289
2015
Q4 		$1.05M Sell
134,099
-12,374
-8% -$107K 0.28% 132
2015
Q3 		$1.24M Buy
146,473
+7,382
+5% +$68.1K 0.27% 116
2015
Q2 		$1.52M Buy
139,091
+36,760
+36% +$472K 0.28% 103
2015
Q1 		$1.43M Buy
+102,331
New +$1.56M 0.27% 124

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Globeflex Capital's INFI Position: Q3 2016 in Review

Globeflex Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2016, closing a stake of 204,399 shares — an estimated $272K sold.

Globeflex Capital first reported a position in INFI in Q1 2015 and held it in 6 quarters. The position peaked at $1.52M in Q2 2015. 99 funds tracked by Wall St. Rank hold INFI as of Q3 2016.

  • Globeflex Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Globeflex Capital sold 204,399 Infinity Pharmaceuticals, Inc. shares in Q3 2016, an estimated $272K.
  • Globeflex Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 6 quarters.
  • Globeflex Capital's Infinity Pharmaceuticals, Inc. position peaked at $1.52M in Q2 2015.
  • 99 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2016.

Based on Globeflex Capital's 13F filing for Q3 2016, filed 9 Nov 2016.